Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel · Delayed Price · Currency is ILS · Price in ILA 123.00
-6.50 (-5.02%)
Feb 17, 2026, 5:24 PM IDT
TLV:IMED Market Cap
TLV:IMED has a market cap or net worth of 4.96 million as of February 20, 2026. Its market cap has increased by 26.80% in one year.
Market Cap
4.96M
Enterprise Value
-8.23M
Revenue
2.76M
Ranking
n/a
PE Ratio
5.38
Stock Price
123.00
Market Cap Chart
Since December 29, 2020, TLV:IMED's market cap has decreased from 40.32M to 4.96M, a decrease of -87.69%. That is a compound annual growth rate of -33.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 4.96M | 0.90% |
| Dec 31, 2025 | 4.92M | 9.43% |
| Dec 30, 2024 | 4.49M | -2.45% |
| Dec 31, 2023 | 4.61M | -19.63% |
| Dec 27, 2022 | 5.73M | -55.66% |
| Dec 30, 2021 | 12.93M | -67.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 124.25B |
| Danel (Adir Yeoshua) | 2.69B |
| Kamada | 1.58B |
| BrainsWay | 1.51B |
| Evogene | 23.91M |
| Bio-View | 23.18M |
| Erika Carmel-Tech | 21.25M |
| Purple Biotech | 18.58M |